JESSICA MEDLEY: Open Payments
NPI 1558077792 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 16 payments from 9 companies in 2025. Trend: 2023 $286 · 2024 $416 · 2025 $518
Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $173 |
| Teva Pharmaceuticals USA, Inc. | 2 | $135 |
| Novo Nordisk Inc | 2 | $46 |
| PFIZER INC. | 2 | $42 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| Seqirus USA Inc | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $22 |
| Astellas Pharma US Inc | 1 | $17 |
Products named: AUSTEDO XR, ZEPBOUND, MOUNJARO, Rybelsus, Flucelvax, PREVNAR 20, Cologuard Collection Kit, Wegovy.
Industry payments across DE — which companies pay providers there.
